Site-specific integration of rotavirus VP6 gene in rabbit β-casein locus by CRISPR/Cas9 system

In Vitro Cellular & Developmental Biology. Animal
Hongli LiDeshun Shi

Abstract

Rotavirus (RV) is the leading cause of viral gastroenteritis in neonates and VP6 protein has been discussed as a potential candidate vaccine. CRISPR/Cas9 was the latest generation of gene editing tools that can mediate the site-specific knock-in of exogenous genes, providing strong support for the expression of recombinant proteins. Here, seeking to design a rotavirus vaccine that would be suitable for both mammary-gland-based production and milk-based administration, rabbit β-casein (CSN2) locus was chosen as the target site to integrate the VP6 gene. The efficiency of inducing mutations in different target sites of rabbit CSN2 locus was analyzed and g4 site seems to be the best one to generate mutations (g4 72.76 ± 0.32% vs g1 30.14 ± 1.93%, g2 38.53 ± 0.75%, g3 52.26 ± 1.16%, P < 0.05). We further compared the knock-in efficiency through cytoplasmic injection of two group mixtures (containing 100 ng/μL Cas9 mRNA or Cas9 protein, 20 ng/μL sgRNA4, and 100 ng/μL donor vector) in rabbit zygotes, though the Cas9 mRNA group induced an HDR efficiency as high as 20.0% ± 2.6% than Cas9 protein group (10.3% ± 3.1%), 37.5% of the knock-in events were partial integration in the target site, when Cas9 protein used in the CRISPR/Cas9 syst...Continue Reading

References

Mar 25, 2000·Science·M D AdamsJ C Venter
Jun 19, 2003·The American Journal of Clinical Nutrition·Bo Lönnerdal
Nov 30, 2005·Transgenic Research·Eric SolerLouis-Marie Houdebine
Jan 6, 2006·The New England Journal of Medicine·Guillermo M Ruiz-PalaciosUNKNOWN Human Rotavirus Vaccine Study Group
Feb 27, 2007·Vaccine·Penelope H Dennehy
Nov 29, 2007·The Pediatric Infectious Disease Journal·Michelle G GoveiaUNKNOWN REST Study Team
Feb 5, 2008·Comparative Immunology, Microbiology and Infectious Diseases·Louis-Marie Houdebine
Dec 14, 2011·Methods in Molecular Biology·Zsuzsanna Bösze, László Hiripi
Oct 3, 2012·Proceedings of the National Academy of Sciences of the United States of America·Daniel F CarlsonScott C Fahrenkrug
Jan 5, 2013·Science·Le CongFeng Zhang
Jan 5, 2013·Science·Prashant MaliGeorge M Church
Jan 31, 2013·Nature Biotechnology·Seung Woo ChoJin-Soo Kim
Feb 7, 2013·ELife·Martin JinekJennifer Doudna
Apr 3, 2013·Cell Research·Bin ShenXingxu Huang
Jul 23, 2013·Nature Biotechnology·Patrick D HsuFeng Zhang
Aug 10, 2013·Nature Biotechnology·Dali LiMingyao Liu
Apr 23, 2014·Nature Biotechnology·Xuebing WuPhillip A Sharp
Sep 4, 2014·Nature Biotechnology·John G DoenchDavid E Root
Sep 7, 2014·Journal of Biotechnology·Jian-Hua ZhangWilliam F Simonds
May 30, 2015·Vaccine·Somayeh JalilvandZabihollah Shoja
Nov 14, 2015·Journal of the American Geriatrics Society·Luísa Helena do Nascimento TôrresAmid Ibrahim Ismail
Apr 22, 2017·The Journal of Infectious Diseases·Eleanor BurnettUmesh D Parashar
Dec 21, 2017·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Adnane LamraniSylvie Escolano
May 16, 2018·Nucleic Acids Research·Jean-Paul Concordet, Maximilian Haeussler

❮ Previous
Next ❯

Citations

Feb 20, 2021·Frontiers in Genetics·Jianglin FanY Eugene Chen

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
in vitro transcription
PCR
electrophoresis
genotyping
cleavage assay

Software Mentioned

SPSS

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.